Target intelligence / Profile preview

Single-minded homolog 1 (SIM1)

Target
SIM1
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH), PAS domain protein, Class E bHLH transcription factor
01

Overview

Single-minded homolog 1 (SIM1) is a transcription factor of the basic helix-loop-helix-PAS (bHLH-PAS) family, which plays a critical role in embryonic and neural development, especially in the formation and function of the paraventricular nucleus of the hypothalamus[1][2][3][4]. SIM1 functions as a heterodimer with ARNT or ARNT2 to regulate gene expression essential for neurogenesis, energy homeostasis, and feeding behavior[1][2][3][4]. Disruption of SIM1, whether through haploinsufficiency or missense variants, is associated with severe early-onset obesity and syndromes resembling Prader-Willi, primarily due to hyperphagia and dysregulation of hypothalamic circuits controlling energy balance[2][3][4]. It does not currently serve as a direct drug target, but its genetic status is important in the differential diagnosis of syndromic or monogenic obesity.

Other names
SIM bHLH transcription factor 1bHLHe14class E basic helix-loop-helix protein 14single-minded family bHLH transcription factor 1single-minded homolog 1, class E basic helix-loop-helix protein 14
02

Mechanism of action

not applicable (no drugs currently target SIM1 directly)

03

Biological functions

Regulation of gene expressionNeurodevelopment (particularly development of the hypothalamic paraventricular nucleus)EmbryogenesisEnergy homeostasis
04

Disease associations

Monogenic obesityPrader-Willi-like syndromeObesity due to SIM1 deficiencyPossibly neurodevelopmental disorders
05

Safety considerations

Genetic manipulation or dysfunction may produce severe obesity, hyperphagia, and hypothalamic abnormalitiespotential developmental effects if altered in utero[2][3]
06

Interacting drugs

none reported
07

Biomarkers

SIM1 loss-of-function variants can serve as a biomarker for diagnosis of monogenic obesity and related neurodevelopmental syndromes[2][3][4]

Beyond the preview

Go deeper on Single-minded homolog 1 (SIM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-minded homolog 1 (SIM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call